Search

everythinglearnresearchcommunity

for

Search:↓

Interest in new and personalized treatments for hair loss is growing.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Hormone treatment caused hair loss, finasteride helped regrowth.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The normal human prostate does not significantly affect blood DHT levels.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Analog 23 is a promising compound for prostate cancer treatment.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Estrogen may help improve COVID-19 outcomes, especially in women.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Growth hormone therapy boosts androgen effects on skin in men.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Estrogen helps keep skin healthy and may make women look younger and more attractive.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.